Biotechnology

Imperial’s interdisciplinary expertise in biotechnology leads the UK field and spans many disciplines. Many of our experts work together as part of the Industrial Biotechnology Hub and Agri-Net which are dedicated to developing innovative solutions for industry and government agencies.

Areas of expertise include…

 

Biotechnology

Synthetic biology, biocatalysis and metabolic engineering, bioinformatics, metabolomics, proteomics, glycomics, nanotechnology, imaging, image analysis and information systems, artificial bioactive material and implants plus neurotechnology.

 

Applied Biosciences

Bioenergy/biorenewables, bioremediation and waste treatment, bioprocessing and bioseparations, biologics, implants, regenerative medicine and tissue engineering, agri-food, brain-related illnesses and blast injury.

 

Microbial Strain Engineering, Design and Improvement.

With increased environmental and economic constraints on industries, the bioproduction of molecules is becoming a sustainable alternative to traditional methods. To scale it up to industrial production, we still need significant improvements in the methods, using genetic engineering and metabolic engineering.

Engineered micro-organisms have a wide range of applications in

  • Oil and Gas – e.g. production of biodiesel, biokerosene, hydrogen, and electricity from renewable sources
  • Pharmaceuticals – e.g. production of active compounds, biosensors, microbiome engineering
  • Chemicals – e.g. production of bulk chemicals or high value compounds
  • Engineering – e.g. production of novel materials and biological circuits
  • Defence

Dr Rodrigo Ledesma-Amaro’s group at Imperial have a vast knowledge of microbial metabolism, and its regulation, in organisms ranging from yeast and fungi to bacteria. Through engineering-based improvements – such as increasing resistance to inhibitors, enabling the use of low-cost substrates and maximising the production of a desired compound – they can ‘tailor’ micro-organisms to perform desired tasks in a cost-efficient manner – and guide you on the downstream process.

The group’s expertise includes:

  • Development of synthetic biology, metabolic engineering and molecular biology tools.
  • Rational metabolic engineering for bioproduction.
  • Metabolic modelling as a tool to identify engineering targets.
  • Decreasing bioproduction cost by strain improvement at different levels.
  • Reliable chassis strains generation.
  • Selecting the best host for each product and process.
  • High-throughput strain improvement techniques.

 

Experts include:

Dr Rodrigo Ledesma-Amaro – leads a research group at the interface of synthetic biology and metabolic engineering. His expertise includes microbial biotechnology and communities, applications in industrial biotechnology and biomedicine.

Advisory services

Product design, research methods, data analysis, technology evaluation for investment, technological innovation, patent evaluation, prototype and protocol development, policy, cyber security and more. Assisting museums, writers, film makers and artists to ensure creations scientifically sound.

Expert insight

Membership of Scientific Advisory Boards and Technical Panels, advice and guidance on drug development programmes, thought leadership, conference speakers, literature reviews and provision of foresight.

Analysis and testing

Use of the world-class specialist facilities and technicians at Imperial for projects ranging from aerodynamic measurements and medical imaging to structural testing and analysis.

Our consultants are world-leading experts in their field, committed to on-going research.

Related Insights

Imperial’s COVID-19 vaccine

Imperial’s COVID-19 vaccine

As the first trials of Imperial’s COVID-19 vaccine candidate got underway in June, the team leading this pioneering work talk though the science of the vaccine and how they will find out whether it protects people from the disease. read more

Life after lockdown: COVID-19 response

Life after lockdown: COVID-19 response

Imperial's experts, from a wide range of disciplines, have and continue to keep us informed about COVID-19 and the coronavirus response, save lives through vaccines and testing - and provide solutions to protect the NHS. read more

Modelling an unprecedented pandemic

Modelling an unprecedented pandemic

During the COVID-19 pandemic, scientists tried to understand the behaviour of the tiny virus particles as well as their effects on very large numbers of human hosts, attempting to bridge these two worlds coherently. But ‘the science’ isn’t a singular entity: it’s highly collaborative, consensus based – and yes, subject to uncertainty. read more

Related case studies

Imperial College London Diabetes Centre

Imperial College London Diabetes Centre

The Imperial College London Diabetes Centre was established in Abu Dhabi, in 2006, by Mubadala and experts from Imperial to address the demand for diabetes care in the UAE. With continued support from Imperial, the centre now operates three branches across Abu Dhabi and Al Ain and public health initiatives. read more

Imperial COVID-19 testing facilities

Imperial COVID-19 testing facilities

Imperial's facility, comprising the UKAS accredited Molecular Diagnostic Unit (MDU) and high-throughput robotic platform for RNA extraction, forms part of the Department of Health and Social Care's partnership with the London Testing Alliance, set-up by MedCity. read more

Latest news

Investing in pumped hydro storage could save up to £690m a year on pathway to net zero

Investing in pumped hydro storage could save up to £690m a year on pathway to net zero

Study by independent researchers for SSE Renewables found that just 4.5GW of new long duration pumped hydro storage with 90GWh of storage could save up to £690m per year in energy system costs by 2050, as the UK transitions to a net-zero carbon emission system. read more

FREE Fetal Heart webinar – ON DEMAND

FREE Fetal Heart webinar – ON DEMAND

Catch up on the third in our series of four, educational webinars exploring Fetal Medicine. In this event we will explore cases where fetal cardiology, fetal medicine, clinical genetics and obstetric management are integrated in one patient pathway. Delivered by Imperial’s Professor Christoph Lees, and supported by GE HealthCare. read more

Power sector’s carbon emissions at 60-year low

Power sector’s carbon emissions at 60-year low

During the last quarter of 2016 carbon emissions from Britain’s power sector fell to their lowest level for 60 years as more coal came off the system making way for renewables. read more